Literature DB >> 23300156

Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemia.

Martin Bienengraeber1, Molly Pellitteri-Hahn, Naoyuki Hirata, Tesfaye M Baye, Zeljko J Bosnjak, Michael Olivier.   

Abstract

Changes in mitochondrial bioenergetics have been proposed to be critical for triggering and effecting anesthetic-induced preconditioning (APC) against cardiac ischemia and reperfusion injury. The objective of this study was to analyze changes in mitochondrial protein levels and link those changes to potential functional changes. A (18)O-labeling method was applied for relative comparison of cardiac mitochondrial samples from control and isoflurane exposed rats before and after ischemia and reperfusion. Wistar rats were exposed to isoflurane for 30 min (APC) or did not receive the anesthetic (control). Rats were subjected to 30 min coronary occlusion and 15 min reperfusion without (ischemia) or after APC (ischemia + APC). The following comparisons were made: control vs. APC, control vs. ischemia, and APC vs. ischemia + APC. Proteins were analyzed by liquid chromatography-mass spectrometry. A total of 98 proteins currently annotated as mitochondrial proteins in the UniProt database were positively identified from three replicate experiments. Most of the changes during APC and ischemia occur in complexes of the electron transport chain. Overall, fewer changes in ETC complexes were found when comparing APC with APC + ischemia than when comparing control and ischemia. This corresponds to the preservation of bioenergetics due to APC after ischemia and reperfusion as indicated by preserved ATP level and generation. APC itself induced changes in complex I, but those changes were not correlated with activity changes in mitochondria after APC. Thus, a proteomic mass spectral approach does not only assess quantitative changes without prior knowledge of proteins, but also allows insight into the mechanisms of ischemia and reperfusion injury and APC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300156      PMCID: PMC3615574          DOI: 10.1152/physiolgenomics.00117.2012

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  28 in total

1.  ZoomQuant: an application for the quantitation of stable isotope labeled peptides.

Authors:  Brian D Halligan; Ronit Y Slyper; Simon N Twigger; Wayne Hicks; Michael Olivier; Andrew S Greene
Journal:  J Am Soc Mass Spectrom       Date:  2005-01-13       Impact factor: 3.109

2.  Simultaneous quantification and identification using 18O labeling with an ion trap mass spectrometer and the analysis software application "ZoomQuant".

Authors:  Wayne A Hicks; Brian D Halligan; Ronit Y Slyper; Simon N Twigger; Andrew S Greene; Michael Olivier
Journal:  J Am Soc Mass Spectrom       Date:  2005-04-15       Impact factor: 3.109

Review 3.  Cardioprotection by volatile anesthetics: new applications for old drugs?

Authors:  Phillip F Pratt; Chen Wang; Dorothee Weihrauch; Martin W Bienengraeber; Judy R Kersten; Paul S Pagel; David C Warltier
Journal:  Curr Opin Anaesthesiol       Date:  2006-08       Impact factor: 2.706

4.  Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways.

Authors:  D Kent Arrell; Steven T Elliott; Lesley A Kane; Yurong Guo; Young H Ko; Pete L Pedersen; John Robinson; Mitsushige Murata; Anne M Murphy; Eduardo Marbán; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2006-08-31       Impact factor: 17.367

5.  Volatile anesthetics evoke prolonged changes in the proteome of the left ventricule myocardium: defining a molecular basis of cardioprotection?

Authors:  A Kalenka; M H Maurer; R E Feldmann; W Kuschinsky; K F Waschke
Journal:  Acta Anaesthesiol Scand       Date:  2006-04       Impact factor: 2.105

6.  The inhibition of mitochondrial respiration by inhalational anaesthetic agents.

Authors:  G M Hall; S J Kirtland; H Baum
Journal:  Br J Anaesth       Date:  1973-10       Impact factor: 9.166

7.  High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry.

Authors:  A Ducret; I Van Oostveen; J K Eng; J R Yates; R Aebersold
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

8.  Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species.

Authors:  Lynda M Ludwig; Dorothee Weihrauch; Judy R Kersten; Paul S Pagel; David C Warltier
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

9.  Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane.

Authors:  D C Warltier; M H al-Wathiqui; J P Kampine; W T Schmeling
Journal:  Anesthesiology       Date:  1988-10       Impact factor: 7.892

10.  Bound volatile general anesthetics alter both local protein dynamics and global protein stability.

Authors:  J S Johansson; H Zou; J W Tanner
Journal:  Anesthesiology       Date:  1999-01       Impact factor: 7.892

View more
  4 in total

1.  Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes.

Authors:  Jessica M Olson; Yasheng Yan; Xiaowen Bai; Zhi-Dong Ge; Mingyu Liang; Alison J Kriegel; Danielle M Twaroski; Zeljko J Bosnjak
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

Review 2.  Anaesthetics as cardioprotectants: translatability and mechanism.

Authors:  C Kikuchi; S Dosenovic; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 3.  Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury.

Authors:  Bhawana Agarwal; David F Stowe; Ranjan K Dash; Zeljko J Bosnjak; Amadou K S Camara
Journal:  Front Physiol       Date:  2014-09-16       Impact factor: 4.566

Review 4.  Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease.

Authors:  María Gómez-Serrano; Emilio Camafeita; Marta Loureiro; Belén Peral
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.